129 related articles for article (PubMed ID: 3314693)
1. [Immunomodulating properties of antitumor antibiotics].
Viadro MM
Antibiot Med Biotekhnol; 1987 Aug; 32(8):611-7. PubMed ID: 3314693
[No Abstract] [Full Text] [Related]
2. Effects of anticancer drugs on the immune system in humans.
Ehrke MJ; Mihich E; Berd D; Mastrangelo MJ
Semin Oncol; 1989 Jun; 16(3):230-53. PubMed ID: 2658084
[No Abstract] [Full Text] [Related]
3. [New antineoplastic antibiotics, new analogs, modifiers of biological reactions and oncogene inhibitors].
Viadro MM; Navashin SM
Antibiot Khimioter; 1991 Feb; 36(2):44-8. PubMed ID: 1708985
[No Abstract] [Full Text] [Related]
4. [Antitumor immunoadjuvant activity and the immunoregulatory mechanisms of yeasts and their components].
Marconi P; Bistoni F
Ann Ist Super Sanita; 1982; 18(3):501-8. PubMed ID: 6765083
[No Abstract] [Full Text] [Related]
5. [Aclacinomycin A: a new antitumor antibiotic].
Egorov LV; Ivanitskaia LP; Navashin SM
Antibiotiki; 1982; 27(7):540-55. PubMed ID: 6753735
[No Abstract] [Full Text] [Related]
6. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators].
Umezawa H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1071-86. PubMed ID: 6191672
[TBL] [Abstract][Full Text] [Related]
7. Antitumor antibiotics and low molecular weight immunomodifiers of microbial origin.
Umezawa H
Cancer Treat Rep; 1984 Jan; 68(1):137-44. PubMed ID: 6692425
[TBL] [Abstract][Full Text] [Related]
8. A review of clinical studies on aclacinomycin A--phase I and preliminary phase II evaluation of ACM.
Oka S
Sci Rep Res Inst Tohoku Univ Med; 1978 Dec; 25(3-4):37-49. PubMed ID: 572582
[No Abstract] [Full Text] [Related]
9. [Immunomodulating effect of levamisole on cell-mediated immunity (author's transl)].
Miwa H; Orita K
Nihon Gan Chiryo Gakkai Shi; 1981 Oct; 16(6):1231-8. PubMed ID: 7037998
[No Abstract] [Full Text] [Related]
10. Small molecular microbial products enhancing immune response.
Umezawa H
Antibiot Chemother (1971); 1978; 24():9-18. PubMed ID: 655681
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of immune responses and possible inhibition of suppressor cells by aclacinomycin A.
Ishizuka M; Takeuchi T; Masuda T; Fukasawa S; Umezawa H
J Antibiot (Tokyo); 1981 Mar; 34(3):331-40. PubMed ID: 6456249
[TBL] [Abstract][Full Text] [Related]
12. [Low molecular weight immunomodulators produced by microorganisms].
Ishizuka M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2709-14. PubMed ID: 6508323
[TBL] [Abstract][Full Text] [Related]
13. Rodorubicin, a new tetraglycosidic anthracycline.
Kraemer HP; Sedlacek HH
Behring Inst Mitt; 1988 Apr; (82):216-30. PubMed ID: 3165634
[TBL] [Abstract][Full Text] [Related]
14. Desaminoanthracyclines from the antibiotic complex ciclamycin.
Bieber LW; da Silva Filho AA; de Méllo JF; de Lima OG; do Nascimento MS; Veith HJ; von der Saal W
J Antibiot (Tokyo); 1987 Sep; 40(9):1335-8. PubMed ID: 3500159
[No Abstract] [Full Text] [Related]
15. Pingyangmycin shows no inhibition on the restoration of depressed hemopoiesis and immune function in mice treated with cyclophosphamide.
Zhang H; Zhen YS
Proc Chin Acad Med Sci Peking Union Med Coll; 1987; 2(4):202-6. PubMed ID: 2453877
[No Abstract] [Full Text] [Related]
16. [The treatment of cancer by anthracyclines].
Brenner J; Brenner HJ
Harefuah; 1983 Mar; 104(5):205-7. PubMed ID: 6582021
[No Abstract] [Full Text] [Related]
17. [Effect of rubomycin C on the formation of hemagglutinins in animals with transplanted tumors].
Shorin VA; Shapovalova SP
Antibiotiki; 1969 Nov; 14(11):991-6. PubMed ID: 5395874
[No Abstract] [Full Text] [Related]
18. [Immunomodulating effects of indomethacin in breast cancer].
Polevaia EB; Chikvashvili BSh; Kupin VI; Letiagin VP
Sov Med; 1987; (8):27-30. PubMed ID: 3423958
[No Abstract] [Full Text] [Related]
19. Lipids, immunity and cancer.
de Echegaray SD; Santiago Delpín EA; Lavergne J
Bol Asoc Med P R; 1982; 74(7-8):231-3. PubMed ID: 6963910
[No Abstract] [Full Text] [Related]
20. [Synthesis of sulfanylalkylpyrimidine derivatives with potential immunomodulating action].
Briel D; Holzer M; Leistner S; Drössler K; Dobner B
Pharmazie; 2003 Oct; 58(10):759-60. PubMed ID: 14609293
[No Abstract] [Full Text] [Related]
[Next] [New Search]
